Author

J. Iwasawa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Evolutionary Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:E. coli· 2 Assay:bulk RNA-seq· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

C. Furusawa· 2 shared H. Kotani· 2 shared M. Kawada· 2 shared T. Maeda· 2 shared A. Sakai· 1 shared A. Shibai· 1 shared K. Tanabe· 1 shared N. Sakata· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 32 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersEvolutionary Biology

C. Furusawa

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Multi-dimensional antibiotic resistance time series reveals the phenotype-based fitness landscape for Escherichia coli

J. Iwasawa, T. Maeda, A. Shibai, H. Kotani, M. Kawada, C. Furusawa

The paper infers a phenotype-based fitness landscape for antibiotic resistance in Escherichia coli using multi-dimensional time-series drug resistance data to predict evolutionary trajectories.

bioRxiv · Aug 23, 2022 · PreprintEvolutionary Biology

High-throughput laboratory evolution and evolutionary constraints in Escherichia coli

T. Maeda, J. Iwasawa, H. Kotani, N. Sakata, M. Kawada, T. Horinouchi, A. Sakai, K. Tanabe, C. Furusawa

This study uses high-throughput lab evolution of E. coli to identify evolutionary constraints and trade-offs in antibiotic resistance.

bioRxiv · Feb 19, 2020Evolutionary Biology